Loading...
The Effects of Ganciclovir and Valganciclovir Antiviral Treatments in Children with Congenital Cytomegalovirus Infection
Journal Title
Readers/Advisors
Journal Title
Term and Year
Publication Date
2016
Book Title
Publication Volume
Publication Issue
Publication Begin
Publication End
Number of pages
Files
Loading...
Poster
Adobe PDF, 357.26 KB
Research Projects
Organizational Units
Journal Issue
Abstract
Congenital cytomegalovirus (cCMV) is one of the leading causes of non-hereditary newborn hearing losses. Typically children with a hearing loss would receive amplification to help combat the loss; however, new research has shown that children who have cCMV can receive antiviral treatments in lieu of amplification. Ganciclovir and valganciclovir are the antiviral treatments that are currently being used. These antiviral treatments help eliminate the viral load in the blood and thus improve the child’s hearing loss.
Citation
DOI
Description
Senior capstone poster, Department of Communication Sciences and Disorders, SUNY Plattsburgh